Table of Contents

May 1987; 36 (5)

Select this article
- H Hartmann,
- I Probst,
- K Jungermann,
- and W Creutzfeldt
Inhibition of glycogenolysis and glycogen phosphorylase by insulin and proinsulin in rat hepatocyte cultures.
Diabetes May 1987 36:551-555; doi:10.2337/diabetes.36.5.551
- Abstract
Select this article
- S Tomlanovich,
- W M Deen,
- H W Jones, 3rd,
- H C Schwartz,
- and B D Myers
Functional nature of glomerular injury in progressive diabetic glomerulopathy.
Diabetes May 1987 36:556-565; doi:10.2337/diabetes.36.5.556
- Abstract
Select this article
- G Paolisso,
- S Sgambato,
- N Passariello,
- A Scheen,
- F D'Onofrio,
- and P J Lefèbvre
Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels.
Diabetes May 1987 36:566-570; doi:10.2337/diabetes.36.5.566
- Abstract
Select this article
- K E Sussman,
- J W Leitner,
- and B Draznin
Cytosolic free-calcium concentrations in normal pancreatic islet cells. Effect of secretagogues and somatostatin.
Diabetes May 1987 36:571-577; doi:10.2337/diabetes.36.5.571
- Abstract
Select this article
- H Gleichmann and
- G F Bottazzo
Progress toward standardization of cytoplasmic islet cell-antibody assay.
Diabetes May 1987 36:578-584; doi:10.2337/diabetes.36.5.578
- Abstract
Select this article
- G A Merrill and
- J H Anderson, Jr
Involvement of endogenous opiates in glucose-stimulated hyperinsulinism of canine endotoxin shock. Inhibition by naloxone.
Diabetes May 1987 36:585-591; doi:10.2337/diabetes.36.5.585
- Abstract
Select this article
- L J Klaff and
- G J Taborsky, Jr
Pancreatic somatostatin is a mediator of glucagon inhibition by hyperglycemia.
Diabetes May 1987 36:592-596; doi:10.2337/diabetes.36.5.592
- Abstract
Select this article
- J Jakobsen,
- P Sidenius,
- H J Gundersen,
- and R Osterby
Quantitative changes of cerebral neocortical structure in insulin-treated long-term streptozocin-induced diabetes in rats.
Diabetes May 1987 36:597-601; doi:10.2337/diabetes.36.5.597
- Abstract
Select this article
- R Yamamoto,
- Y Iwamoto,
- H Sakura,
- N Yoshioka,
- S D Hsieh,
- A Matsuda,
- and T Kuzuya
Reduced urinary insulin clearance in patient with abnormal insulinemia.
Diabetes May 1987 36:602-606; doi:10.2337/diabetes.36.5.602
- Abstract
Select this article
- R Prager,
- P Wallace,
- and J M Olefsky
Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects.
Diabetes May 1987 36:607-611; doi:10.2337/diabetes.36.5.607
- Abstract
Select this article
- R Osterby,
- H J Gundersen,
- G Nyberg,
- and M Aurell
Advanced diabetic glomerulopathy. Quantitative structural characterization of nonoccluded glomeruli.
Diabetes May 1987 36:612-619; doi:10.2337/diabetes.36.5.612
- Abstract
Select this article
- M K Sinha,
- W J Pories,
- E G Flickinger,
- D Meelheim,
- and J F Caro
Insulin-receptor kinase activity of adipose tissue from morbidly obese humans with and without NIDDM.
Diabetes May 1987 36:620-625; doi:10.2337/diabetes.36.5.620
- Abstract
Select this article
- L Pénicaud,
- P Ferré,
- J Terretaz,
- M F Kinebanyan,
- A Leturque,
- E Doré,
- J Girard,
- B Jeanrenaud,
- and L Picon
Development of obesity in Zucker rats. Early insulin resistance in muscles but normal sensitivity in white adipose tissue.
Diabetes May 1987 36:626-631; doi:10.2337/diabetes.36.5.626
- Abstract
Select this article
- R A Jackson,
- M I Hawa,
- J B Jaspan,
- B M Sim,
- L Disilvio,
- D Featherbe,
- and A B Kurtz
Mechanism of metformin action in non-insulin-dependent diabetes.
Diabetes May 1987 36:632-640; doi:10.2337/diabetes.36.5.632
- Abstract
Select this article
- T Mandrup-Poulsen,
- G A Spinas,
- S J Prowse,
- B S Hansen,
- D W Jørgensen,
- K Bendtzen,
- J H Nielsen,
- and J Nerup
Islet cytotoxicity of interleukin 1. Influence of culture conditions and islet donor characteristics.
Diabetes May 1987 36:641-647; doi:10.2337/diabetes.36.5.641
- Abstract
Select this article
- B J Frankel and
- J Sehlin
Abnormalities in glucose-stimulated insulin release, 45Ca uptake, and 86Rb efflux in diabetic Chinese hamster islets.
Diabetes May 1987 36:648-653; doi:10.2337/diabetes.36.5.648
- Abstract
Select this article
- I G Fantus,
- R Chayoth,
- L O'Dea,
- E B Marliss,
- J F Yale,
- and M Grose
Insulin binding and glucose transport in adipocytes in neonatal streptozocin-injected rat model of diabetes mellitus.
Diabetes May 1987 36:654-660; doi:10.2337/diabetes.36.5.654
- Abstract
Select this article
- F L Dunn,
- P B Carroll,
- and W F Beltz
Treatment with artificial beta-cell decreases very-low-density lipoprotein triglyceride synthesis in type I diabetes.
Diabetes May 1987 36:661-666; doi:10.2337/diabetes.36.5.661
- Abstract
Select this article
- H Sugimoto,
- D J Franks,
- L Lecavalier,
- J L Chiasson,
- and P Hamet
Therapeutic modulation of growth-promoting activity in platelets from diabetics.
Diabetes May 1987 36:667-672; doi:10.2337/diabetes.36.5.667
- Abstract
Select this article
- E Ipp,
- Y Sinai,
- B Bar-Oz,
- R Nesher,
- and E Cerasi
Somatostatin impairs clearance of exogenous insulin in humans.
Diabetes May 1987 36:673-677; doi:10.2337/diabetes.36.5.673
- Abstract

Current Issue

February 2012, 61 (2)

Print ISSN: 0012-1797
Online ISSN: 1939-327X

Diabetes

Inhibition of glycogenolysis and glycogen phosphorylase by insulin and proinsulin in rat hepatocyte cultures.

Functional nature of glomerular injury in progressive diabetic glomerulopathy.

Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels.

Cytosolic free-calcium concentrations in normal pancreatic islet cells. Effect of secretagogues and somatostatin.

Progress toward standardization of cytoplasmic islet cell-antibody assay.

Involvement of endogenous opiates in glucose-stimulated hyperinsulinism of canine endotoxin shock. Inhibition by naloxone.

Pancreatic somatostatin is a mediator of glucagon inhibition by hyperglycemia.

Quantitative changes of cerebral neocortical structure in insulin-treated long-term streptozocin-induced diabetes in rats.

Reduced urinary insulin clearance in patient with abnormal insulinemia.

Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects.

Advanced diabetic glomerulopathy. Quantitative structural characterization of nonoccluded glomeruli.

Insulin-receptor kinase activity of adipose tissue from morbidly obese humans with and without NIDDM.

Development of obesity in Zucker rats. Early insulin resistance in muscles but normal sensitivity in white adipose tissue.

Mechanism of metformin action in non-insulin-dependent diabetes.

Islet cytotoxicity of interleukin 1. Influence of culture conditions and islet donor characteristics.

Abnormalities in glucose-stimulated insulin release, 45Ca uptake, and 86Rb efflux in diabetic Chinese hamster islets.

Insulin binding and glucose transport in adipocytes in neonatal streptozocin-injected rat model of diabetes mellitus.

Treatment with artificial beta-cell decreases very-low-density lipoprotein triglyceride synthesis in type I diabetes.

Therapeutic modulation of growth-promoting activity in platelets from diabetics.

Somatostatin impairs clearance of exogenous insulin in humans.

This Issue

Current Issue